Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MyStart Health vs YOURx Health

MyStart Health
Graded #168

Lower grade

vs+2.9000000000000057
YOURx Health
Graded #109

Higher grade

The verdict

YOURx Health takes it — 70/100 to 67.1/100.

YOURx Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. YOURx Health (yourxhealth.com) is a compounded GLP-1 telehealth platform powered by the MD Integrations provider network.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueYOURx Health +19
48
67
Dose & formulationMyStart Health +8
83
75
Clinical oversightMyStart Health +4
84
80
Labs & monitoringYOURx Health +9
66
75
FulfillmentMyStart Health +23
78
55
Contract termsYOURx Health +24
31
55
MyStart Health · left barYOURx Health · right bar

The numbers

MetricMyStart HealthYOURx Health
WeighScore67.1/10070/100
GradeCC
Scorecard rank#168#109
Semaglutide$299/mo (all doses, compounded)$179/mo (compounded)
Tirzepatide$299/mo (all doses, compounded)$199/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
MyStart Health

Graded #168 · C

Strengths

  • Price Lock Guarantee — your $299 base rate doesn't rise as your dose escalates
  • Fast onboarding: roughly 5-minute intake, 24-hour prescription turnaround, 2–4 day shipping
  • 24/7 care team access with unlimited clinician messaging included
  • LegitScript certified
  • Clear Section 503A compounding disclosure on every landing page

Where it loses points

  • Not BBB accredited — C+ rating with 10 complaints, mostly shipping delays and support access
  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Markets oral tirzepatide, but no FDA-approved oral tirzepatide exists
  • Very new company (incorporated May 2024) with a limited track record
  • Pharmacy partners not named, so 503A compliance can't be independently verified
YOURx Health

Graded #109 · C

Strengths

  • Lab monitoring included (per the home page) — most peer platforms gate labs as add-ons or skip them entirely
  • Physician video consultation with 'board-certified provider' disclosed
  • MD Integrations network is a recognized white-label clinical platform
  • Transparent published pricing: semaglutide injection $179/mo, tirzepatide injection $199/mo, oral RDT tablets $159-$179/mo

Where it loses points

  • Parent company / legal entity name NOT publicly disclosed — material YMYL transparency gap
  • NO LegitScript / NABP / PCAB / BBB seal displayed — material trust-signal gap vs peer platforms
  • Per-state availability shown as 'Coverage 0 States' (placeholder metric) — appears the home page is incomplete or the platform is pre-launch
  • Pharmacy partners NOT publicly named
  • Confidence LOW until the platform exposes more public information

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard